Safety and efficacy of romiplostim in children and adolescents with Immune thrombocytopenia: A systematic review

Safety and efficacy of romiplostim in children and adolescents with Immune thrombocytopenia: A systematic review

Objective: To evaluate the efficacy and safety of romiplostim (thrombopoietin-receptor agonist) in the treatment of pediatric immune thrombocytopenia (ITP). Methods: Searches were conducted in MEDLINE, EMBASE, LILACS, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov (from Januar...

Full description

Bibliographic Details
Main Authors: Fernanda Lubiana de Oliveira, Fernanda Silva Sequeira, Marlene Pereira Garanito
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Purpura
Thrombocytopenic
Idiopathic
Romiplostim
Pediatrics
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137922014262

Internet

http://www.sciencedirect.com/science/article/pii/S2531137922014262

Similar Items